LipoCure Ltd.

Healthcare 📍 Jerusalem, Israel 👥 11-50 employees 📅 Founded 2006

LipoCure focuses on the development of nano-drugs based on liposomes. LipoCure utilizes the vast experience gained by Professor Yechezkel Barenholz, one of the major inventors and developers of the first FDA-approved nano-drug, Doxil®. Doxil is an anti-cancer drug considered as one of the gold standards of nano-drug de

🌐 Website in LinkedIn ← All Companies

📊 Company Overview

Sector

Healthcare

Country

Israel

Employees

11-50

Founded

2006

Cloud

Unknown

Email

Microsoft 365

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Microsoft 365
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$108K – $270K / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	WordPress
Frontend Stack	🔒 Subscribers only

Detected from LipoCure Ltd.'s public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

1-10 ☁️ Unknown

Central Printing Group

1-10 ☁️ Unknown

Ortho Clinical Diagnostics Holdings Plc

1-10 ☁️ Azure

Data detected 2026-06-13 · Methodology · Suggest a correction